High sodium intake isn't the only cause of hypertension. Certain habits can also spike your blood pressure and contribute to ...

Guggenheim Partners called Insmed’s Phase IIb readout “impressive across the board,” with an efficacy profile that positions ...

TPIP trial exceeds expectations; Phase 3 studies to begin by early 2026 Shares in Insmed Incorporated (NASDAQ:INSM) closed 28 ...

Shares of Insmed (INSM) jumped nearly 30% Tuesday after the biopharmaceutical company reported positive results from a Phase ...

Find lists of blood pressure medications commonly used to treat hypertension and the names of medications prescribed less ...

The ZENITH study found that in high-risk PAH, add-on sotatercept was tied to lower risk for death from any cause, lung ...

Insmed said that it will immediately engage with the U.S. Food and Drug Administration (FDA) regarding a late-stage study ...

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

Adding more lines of treatment may reduce the risk of rehospitalization among adults with PAH who are taking only one ...

In this randomized controlled trial of patients with pulmonary arterial hypertension (PAH) and high risk of mortality, ...

The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare ...

Low-dose metformin delivered to the pulmonary arteries using lipid-based nanocapsules, safely eased signs of PAH in rats.